CVS to strengthen reproductive health data protections after request from investment group

Environmental, social and governance investment group Arjuna Capital is claiming a win after CVS Health committed to strengthening its reproductive health data privacy protections following a shareholder proposal from the activist investment group.

Advertisement

Arjuna filed the request after the Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization, which ended the constitutional right to an abortion in the U.S. CVS collects sensitive information on over-the-counter reproductive health medications, such as the emergency contraceptive Plan B. 

The activist investment group filed seven shareholder proposals with CVS focusing on protecting reproductive health data, according to a March 28 Arjuna news release.

“CVS is taking the steps necessary to protect its customers’ privacy and data in a post-Dobbs world,” Natasha Lamb, managing partner at Arjuna Capital, said in the release. “It’s clear that threats to women’s privacy are also a threat to CVS’s business, brand, and investors.”

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Disruptors

Advertisement

Comments are closed.